1-6 of 6
Anca Prica, MD FRCP(C)
Close
Sort by
Journal Articles

Tolerability and Efficacy of Post Transplant Lenalidomide Maintenance Therapy in Multiple Myeloma: A Real World Single Centre Experience

Chloe Yang, MD BS, Haiyan Jiang, PhD, Esther Masih-Khan, PhD, Christine I Chen, MD FRCP(C), Anca Prica, MD FRCP(C), Donna Reece, MD FRCP(C), Rodger Tiedemann, MBChB, PhD, Suzanne Trudel, MD FRCP(C), Vishal Kukreti, MD FRCP(C)
Journal: Blood
Blood (2017) 130 (Supplement 1): 3462.
https://doi.org/10.1182/blood.V130.Suppl_1.3462.3462
Published: 2017
Journal Articles

Real World Outcomes of Newly Diagnosed High-Risk Multiple Myeloma Patients Treated at Princess Margaret Cancer Centre: A Retrospective Chart Review

Donna Reece, BA, MD, John Mikhaeil, Esther Masih-Khan, PhD, Eshetu G Atenafu, M.Sc., P.Stat, Christine I Chen, MD FRCP(C), Vishal Kukreti, MD FRCP(C), Anca Prica, MD FRCP(C), Rodger Tiedemann, MBChB, PhD, Suzanne Trudel, MD FRCP(C)
Journal: Blood
Blood (2017) 130 (Supplement 1): 2010.
https://doi.org/10.1182/blood.V130.Suppl_1.2010.2010
Published: 2017
Journal Articles

Toxicity and Outcomes of Autologous Stem Cell Transplant in Multiple Myeloma Patients with Renal Insufficiency: An Institutional Comparison between Two Eras

Amanda Li, MD BSc, Eshetu G Atenafu, M.Sc., P.Stat, Rosanne St. Bernard, MD MSc, Esther Masih-Khan, PhD, Donna Reece, MD FRCP(C), Norman Anthony Franke, MD, Rodger Tiedemann, MBChB, PhD, Anca Prica, MD FRCP(C), Suzanne Trudel, MD FRCP(C), Vishal Kukreti, MD FRCP(C), Christine I Chen, MD FRCP(C)
Journal: Blood
Blood (2017) 130 (Supplement 1): 4537.
https://doi.org/10.1182/blood.V130.Suppl_1.4537.4537
Published: 2017
Journal Articles

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Anca Prica, MD FRCP(C), Annette E Hay, Michael Crump, MD, Nicole Mittman, Lois E. Shepherd, Ralph Meyer, MDFRCPC, Kevin Imrie, MD, Nancy A. Risebrough, Marina S Djurfeldt, MSc, Bingshu E. Chen, Matthew Cheung, MD MS, FRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4673.
https://doi.org/10.1182/blood.V130.Suppl_1.4673.4673
Published: 2017
Journal Articles

A Phase II Clinical Trial of the Pan PI3K Inhibitor, Buparlisib, for the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia: Canadian Cancer Trials Group IND.216

Sarit Assouline, MD, Lilian Amrein, PhD, Versha Banerji, MD FRCP, Stephen Caplan, MD, Carolyn Jane Owen, MD FRCPC, Wanda Hasegawa, MD, Sue Robinson, MD, Sudeep Shavikumar, MD, Anca Prica, MD FRCP(C), Anthea Peters, MSc, MD FRCPC, Linda Hagerman, Laura Rodriguez, Tanya Skamene, MD, Lawrence Panasci, MD, Bingshu E. Chen, Annette E Hay
Journal: Blood
Blood (2017) 130 (Supplement 1): 4319.
https://doi.org/10.1182/blood.V130.Suppl_1.4319.4319
Published: 2017
Journal Articles

Targeted-Capture Sequencing Approach to V(D)J Rearrangement, Immunoglobulin (Ig) Translocation and Mutation Detection in Multiple Myeloma (MM): Potential Applications in Minimal Residual Disease (MRD) Analysis and Comparison to Multiparameter Flow Cytometry (MFC) in the Myeloma Canada Research Network (MCRN) 001 Study with Intravenous Busulfan and Melphalan (BuMel) Conditioning Followed By Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM)

Signy Chow, MD FRCP(C), Donna Reece, MD FRCP(C), Jonathan J. Keats, PhD, P. Leif Bergsagel, MD, Nizar J. Bahlis, MD, Paola Neri, MD, Giovanni Piza Rodriguez, MD, Michael Sebag, MD PhD, Darrell J White, MD, Kevin Song, MD FRCP(C), Terrance Comeau, MD, Christopher P. Venner, MD, Christine I Chen, MD FRCP(C), Jean Roy, MD, Martha L Louzada, MD, Julie Stakiw, MD FRCP(C), Andrea Kew, MDFRCP(C), Vishal Kukreti, MD FRCP(C), Anca Prica, MD FRCP(C), Rodger Tiedemann, MBChB, PhD, Mariela Aura Pantoja, PhD MSc, Harminder Kaur Paul, MSc, Trevor J. Pugh, PhD, Suzanne Trudel, MD FRCP(C)
Journal: Blood
Blood (2017) 130 (Supplement 1): 3057.
https://doi.org/10.1182/blood.V130.Suppl_1.3057.3057
Published: 2017